Par Pharmaceutical is recalling 218 bottles of Phenoxybenzamine Hydrochloride (Phenoxybenzamine) 10mg capsules because testing revealed the product failed to meet impurity and degradation specifications. This prescription medication is used to treat symptoms of high blood pressure and sweating related to certain adrenal gland tumors. No injuries or adverse events have been reported in connection with this recall.
The medication may contain impurities or breakdown products that exceed safe regulatory standards. This could potentially reduce the effectiveness of the treatment or cause unexpected side effects for patients.
You have 2 options:
Quantity affected: 218 bottles.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.